---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-006866"
form_type: "8-K"
ticker: "CRVS"
cik: "0001626971"
company_name: "Corvus Pharmaceuticals, Inc."
filed_at: "2022-10-28T23:59:59+00:00"
generated_at: "2026-06-22T22:43:41.498292+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Corvus Pharma receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Nasdaq notified Corvus on Oct 25, 2022 that its stock failed to maintain minimum $1.00 bid price for 30 consecutive business days.
- Company has 180 calendar days, until April 24, 2023, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If non-compliance persists, Corvus may transfer to Nasdaq Capital Market and seek an additional 180-day grace period.
- Corvus may consider a reverse stock split or other options to cure the deficiency but no assurance of success.

## SEC filing metadata
- accession: 0001171843-22-006866
- form_type: 8-K
- ticker: CRVS
- cik: 0001626971
- company_name: Corvus Pharmaceuticals, Inc.
- filed_at: 2022-10-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626971/000117184322006866/0001171843-22-006866-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626971/000117184322006866/f8k_102722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-006866
- JSON: https://secwatch.observer/filing/0001171843-22-006866.json
- Plain text: https://secwatch.observer/filing/0001171843-22-006866.txt

## Key facts
- Listing & Compliance Notices
  Corvus Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: ule 5450(a)(1) (the “Minimum Bid Price Requirement”). Nasdaq’s written notice does not result in the immediate delisting
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626971/000117184322006866/0001171843-22-006866-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.